COVID-19: J&J’s Vaccine Candidate Registers Strong Immune Response in Early Trials
By Eduardo Longoria Johnson & Johnson’s lead COVID-19 vaccine candidate, Janssen COVID-19 (JNJ-78436735), is a viral vector vaccine constructed from a modified adenovirus that carries the genetic instructions for SARS-CoV-2’s spike …
Read More